China suggests Covid-19 originated in US in response to Trump allegation

Sign up now: Get ST's newsletters delivered to your inbox

FILE PHOTO: Desks sit empty inside the Grand Army of the Republic Building as employees continue to work remotely due to the coronavirus disease (COVID-19) pandemic in Detroit, Michigan, U.S., June 8, 2021. REUTERS/Emily Elconin/File Photo

Offices across the world were emptied at the height of the Covid-19 pandemic in 2021.

PHOTO: REUTERS

Follow topic:

BEIJING – China restated its case that Covid-19 may have originated in the United States in a white paper on its pandemic response released on April 30 after President Donald Trump’s administration blamed a lab leak in China.

The White House launched a Covid-19 website on April 18 in which it said the coronavirus came from a lab leak in China while criticising former president Joe Biden, former top US health official Anthony Fauci and the World Health Organisation (WHO).

In the white paper, released by the official Xinhua news agency, China accused the US of politicising the matter of the origins of Covid-19. It cited a Missouri lawsuit that resulted in a US$24 billion (S$31 billion) ruling against China for hoarding protective medical equipment and covering up the outbreak.

China shared relevant information with the WHO and the international community in a timely manner, the white paper said, emphasising that a joint study by the WHO and China concluded that a lab leak was “extremely unlikely”.

The US should not continue to “pretend to be deaf and dumb” but respond to the legitimate concerns of the international community, the white paper said.

“Substantial evidence suggested that Covid-19 might have emerged in the United States earlier than its officially claimed timeline and earlier than the outbreak in China,” it said.

The Central Intelligence Agency (CIA) said in January the pandemic was more likely to have emerged from a lab in China than from nature after the agency had for years said it could not reach a conclusion on the matter.

CIA said it had “low confidence” in its new assessment and noted that both lab origin and natural origin remain plausible.

An official at China’s National Health Commission said the next step in origin-tracing work should focus on the US, according to Xinhua, which cited a statement about the white paper. REUTERS

See more on